# Nuclide record paper-clarinet-lanreotide-nejm-2014 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-clarinet-lanreotide-nejm-2014/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-clarinet-lanreotide-nejm-2014" ;
  schema:name "CLARINET: lanreotide in metastatic enteropancreatic neuroendocrine tumours"@en ;
  schema:description "The long-acting somatostatin analogue lanreotide roughly halved the risk of progression in non-functioning gut and pancreatic neuroendocrine tumours, extending the use of these drugs from symptom control to slowing tumour growth."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-clarinet-lanreotide-nejm-2014/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1316158>, <https://pubmed.ncbi.nlm.nih.gov/25014687/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1316158> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Caplin ME, Pavel M, Ćwikła JB, et al." ;
  nuclide:indications <https://nuclide.cc/indications/pancreatic-net/>, <https://nuclide.cc/indications/small-intestinal-net/> ;
  nuclide:journals <https://nuclide.cc/journals/nejm/> .